Intalight was founded by a group of scientists and industry veterans of Silicon Valley in 2014 with a core mission to develop the most advanced ophthalmic technologies. In 2015, the company’s base of operations moved to mainland China, and there are now three sites in Silicon Valley, Shanghai, and Luoyang.

In 2019, Intalight released the first Swept-Source Optical Coherence Tomography (OCT) device that combines Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection and Multimodal imaging capabilities, abbreviated as DREAM OCT™.

The powerful imaging device has become an indispensable tool for many ophthalmologists in not only their daily clinical use but also their exploration of the research frontiers. To date, over 170 papers have been published in peer-reviewed journals based on the findings using DREAM OCT™ devices.

Intalight will continue the innovation and push the limit of technologies. The product portfolios are extending from ophthalmic diagnostic devices to operational instruments. In doing so, Intalight aims to empower ophthalmologists and benefit the patients worldwide.